Similar companies
| Company | Stocktwits Mentions | |
|---|---|---|
 |
AmgenAMGN |
20 0% |
 |
Gilead SciencesGILD |
83 1.2% |
 |
Catalyst PharmaceuticalsCPRX |
6 0% |
 |
Inovio PharmaceuticalsINO |
76 1.3% |
 |
Anavex Life SciencesAVXL |
286 12% |
Month over Month
Est. daily mentions on Stocktwits.
| Jan 2026 | 5 | |
| Dec 2025 | 5 | |
| Nov 2025 | 8 | |
| Oct 2025 | 1 | |
| Sep 2025 | 4 |
How often is Inhibikase Therapeutics mentioned on StockTwits?
Inhibikase Therapeutics was mentioned an estimated 0 times in discussions on StockTwits yesterday.
Analyzing Stocktwits Mentions, how is Inhibikase Therapeutics performing compared to its industry peers?
Inhibikase Therapeutics underperforms its industry peers when it comes to Stocktwits Mentions, ranking dead last.
What does a high frequency of StockTwits mentions indicate for Inhibikase Therapeutics' market sentiment?
A high frequency of mentions on StockTwits for Inhibikase Therapeutics could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Inhibikase Therapeutics' stock, potentially signaling bullish or bearish trends based on the context of the discussions.
How often does AltIndex update information on Inhibikase Therapeutics' mentions on StockTwits?
AltIndex updates the data on Inhibikase Therapeutics' mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Inhibikase Therapeutics' on the platform.
Sign up and get more insights on Inhibikase Therapeutics.
